- Home
- DYN vs NOMD Comparison
DYN vs NOMD Comparison
Compare DYN & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- NOMD
- Stock Information
- Founded
- DYN 1984
- NOMD 2014
- Country
- DYN United States
- NOMD United Kingdom
- Employees
- DYN N/A
- NOMD N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- NOMD Packaged Foods
- Sector
- DYN Health Care
- NOMD Consumer Staples
- Exchange
- DYN Nasdaq
- NOMD Nasdaq
- Market Cap
- DYN 2.6B
- NOMD 2.7B
- IPO Year
- DYN 2020
- NOMD N/A
- Fundamental
- Price
- DYN $14.01
- NOMD $18.86
- Analyst Decision
- DYN Strong Buy
- NOMD Strong Buy
- Analyst Count
- DYN 10
- NOMD 3
- Target Price
- DYN $50.78
- NOMD $22.00
- AVG Volume (30 Days)
- DYN 2.1M
- NOMD 582.9K
- Earning Date
- DYN 03-04-2025
- NOMD 03-03-2025
- Dividend Yield
- DYN N/A
- NOMD 3.64%
- EPS Growth
- DYN N/A
- NOMD 4.33
- EPS
- DYN N/A
- NOMD 1.37
- Revenue
- DYN N/A
- NOMD $3,420,923,487.00
- Revenue This Year
- DYN N/A
- NOMD $3.79
- Revenue Next Year
- DYN N/A
- NOMD $2.63
- P/E Ratio
- DYN N/A
- NOMD $13.37
- Revenue Growth
- DYN N/A
- NOMD 1.10
- 52 Week Low
- DYN $13.07
- NOMD $15.43
- 52 Week High
- DYN $47.45
- NOMD $20.05
- Technical
- Relative Strength Index (RSI)
- DYN 37.85
- NOMD 68.24
- Support Level
- DYN $13.59
- NOMD $17.64
- Resistance Level
- DYN $14.50
- NOMD $18.44
- Average True Range (ATR)
- DYN 0.98
- NOMD 0.48
- MACD
- DYN 0.32
- NOMD 0.08
- Stochastic Oscillator
- DYN 22.90
- NOMD 96.91
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
About NOMD Nomad Foods Limited
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals. It sells its products primarily through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.